Antibacterial therapy does not fully protect against anthrax because of severe systemic intoxication. Lysosomal processing of anthrax lethal toxin (LTX) is a key event in the disease pathogenesis, and agents interfering with this process, like chloroquine (CQ), may have practical applications. Although LTX is known to induce T-cell suppression, precise mechanisms of this phenomenon are not completely characterized. In the present study, we investigated alterations of lymphocyte ultrastructure caused by LTX and associated with favorable effect of CQ on the LTX-related dysfunction. Peripheral blood lymphocytes were activated via CD3 crosslinking in the presence or absence of LTX and CQ, and examined by transmission electron microscopy, flow cytometry and immunoblotting. Crosslinking of CD3 induced ultrastructural signs of lymphocyte activation, mostly disappeared after LTX treatment. The cell ultrastructure was well preserved in LTX-treated cells, despite dose-and time-dependent inhibition of T-cell function associated with impaired activation of mitogen-activated protein kinase. Regardless of intracellular signaling abnormalities, LTX did not decrease T-cell viability. CQ restored expression of CD69 (Po0.001) and improved phosphorylation of p38 (P ¼ 0.022) in LTXexposed T lymphocytes. The exposure of cells to CQ, with or without LTX, led to appearance of many phagolysosomes with heterogeneous content, possibly representing unprocessed internalized material. In conclusion, LTX suppressed Tcell functions, but did not affect the viability and caused no ultrastructural damage. Ultrastructural observations indicated that CQ reduced harmful effects of LTX, possibly by interfering with lysosomal activity.
A lethal toxin (LTX) produced by B. anthracis consists of two associated proteins: protective antigen (PA) and lethal factor (LF). 1 Susceptibility of various mammalian cells to harmful effects of anthrax toxins is associated with expression of cell surface receptors for PA. 2 PA binds to these cell surface molecules and after proteolytic activation forms membranepenetrating heptamers capable of LF and edema toxin binding. 1 The cell membrane-bound PA-LF complexes are internalized and after acidification in phagolysosomes dissociate resulting in translocation of LF into the cytosol. 1, 3 It has been shown that LF proteolytically cleaves several mitogen-activated protein kinase kinases (MAPKK), including MEK1/2, MKK3/4 and MKK6/7, and thereby disrupts regulation of major cellular functions by inhibition of intracellular signaling through MAPK cascades. 4, 5 Anthrax toxins derange the immune system facilitating progress of the infection. 1, 6, 7 Specifically, LTX kills macrophages (Mf) 8, 9 and inactivates the adaptive immune system. It has been demonstrated that LTX affects dendritic cell functions 10, 11 and therefore impairs antigen recognition and activation of T cells. Several in vitro reports have shown that LTX inhibits interleukin (IL)-2 production in Jurkat cells 12 and interrupts signaling in human T cells. 13, 14 In addition, Comer et al 15 have revealed the direct LTX-induced inactivation of T cells in vivo.
Currently recommended antibacterial therapy alone does not completely protect against anthrax because of the severe systemic intoxication 6 and should be combined with other therapeutic approaches. One such approach may be affecting key steps in the development of intoxication, for instance lysosomal processing of LTX. Chloroquine (CQ) is a pharmacological agent that interferes with lysosome functions and thereby disrupts this processing. CQ has protected isolated Mf from deadly effects of LTX 16, 17 and even improved survival of LTX-treated mice. 18 In light of these findings, we hypothesized that favorable effects of CQ were expanded beyond Mf, providing survival and/or functional benefits to other cell types. This assumption was further supported by demonstration of the ability of CQ to protect cultured epithelial cells from anthrax toxins 19 and to reduce suppression of T lymphocytes exposed to LTX.
14 However, precise mechanisms of this protection are not completely understood. The present study was aimed to investigate alterations of lymphocyte ultrastructure caused by LTX and associated with favorable effect of CQ on the LTX-related dysfunction.
MATERIALS AND METHODS Cell Culture
Peripheral blood was obtained from healthy adult volunteers according the protocol approved by the Helsinki Committee of the Technion Faculty of Medicine. Peripheral blood mononuclear cells (PBMC) were isolated by centrifugation in the Histopaque 1077 (Sigma-Aldrich Co., Rehovot, Israel), and depleted from monocytes by adherence to plastic Petri dishes to separate peripheral blood lymphocytes (PBL). PBL fractions were more than 85% pure, and the cell viability was greater than 95% as determined by propidium iodide (PI, Sigma) staining and flow cytometry. Experiments were designed as described.
14 Briefly, 10 6 PBL were resuspended in RPMI 1640 culture medium (Biological Industries, Kibbutz Beth Haemek, Israel) and incubated for different time periods at 371C and 5% CO 2 . Cells were activated by CD3 crosslinking with 1 mg/ml mouse anti-human CD3 monoclonal antibody (mAb; clone UCHT1) and 1:100 rabbit anti-mouse IgG (both from Serotec Ltd, Kidlington, UK). Recombinant PA, LF and mutant LF were purchased from List Biological Laboratories Inc. (Campbell, CA, USA). PA was added to the cells at concentration of 0.5 mg/ml, whereas LF at concentrations of 10, 100, 1000 and 10 000 ng/ml. In part of experiments, CQ (Sigma) was used at concentration of 100 mM.
Transmission Electron Microscopy
Cell ultrastructure was assayed as described. 20 Briefly, control and treated cells were fixed in 2% glutaraldehyde in 0.1 M sodium cacodylate buffer, pH 7.2, post-fixed in 2% OsO 4 , dehydrated in ethanol series and embedded in epoxy. Ultrathin sections were stained with 1% uranyl acetate and 1% lead citrate, viewed and photographed with JEOL 100B (Tokyo, Japan) electron microscope operated at 60 kV. Three or more 300-mesh copper grids were examined from each sample in a blinded fashion. Cell Viability LTX-induced T-cell apoptosis was assessed by triple staining with fluorescein isothiocyanate (FITC)-labeled anti-CD3 mAb, cyanine 5 (Cy5)-labeled annexin V and PI, followed by flow cytometry. The procedure was carried out according to the instructions of the annexin V kit manufacturer (MBL Medical & Biological Laboratories Co. Ltd, Nagoya, Japan) as described previously. 20, 21 The incidence of apoptotic T cells was expressed as percentage of CD3
Immunoblotting
After the indicated treatments, cell extracts were prepared using protein extraction reagent (Pierce Biotechnology, Inc., Rockford, IL, USA), and aliquots of cell extract (30 mg of protein) were resolved by 10% polyacrylamide gel electrophoresis exactly as described. 14 After electrophoresis and transfer, proteins were identified using a two-step chemiluminiscent detection (Pierce). Primary rabbit antibody against total and phosphorylated forms of p38 MAPK (Cell Signaling Technology, Inc., Beverly, MA, USA) was used. Films were analyzed by a Vilber Lourmat imaging system (Lyon, France) and the percentage of phosphorylated protein was calculated as fractions of total p38 protein. The experiments were repeated four times with cells isolated from different donors.
Statistical Analysis
Data are presented as mean7s.e.m. Comparison of the differences between groups (independent variables) was performed with one-way analysis of variance (ANOVA) followed by Neuman-Keuls post hoc test. P-values of o0.05 were considered statistically significant.
RESULTS

Effect of LTX on Ultrastructure of Lymphocytes
The LTX-induced suppression of lymphocyte functions has been amply documented. [12] [13] [14] [15] In the present study, we investigated alterations of lymphocyte ultrastructure associated with functional abnormalities induced by LTX. Crosslinking of CD3 markedly changed the ultrastructure of lymphocytes ( Figure 1a ). Nuclei frequently appeared indented and small electron lucent vacuoles, profiles of rough endoplasmic reticulum, free ribosomes and Golgi cisterns were present in the relatively wide rim of the cytoplasm. Electron-dense bodies, probably small lysosomes, were frequent and many mitochondria displayed variability of size and shape. In LTXtreated cells, ultrastructure was well preserved, and no evidence of organelle damage was found (Figure 1b) . The cells usually showed reversal to the basic ultrastructure as observed before activation (untreated cells, Figure 1c ): large, round-or oval-shaped nuclei and a narrow rim of cytoplasm containing few mitochondria, scant elements of endoplasmic reticulum and one or two electron-dense lysosomes were conspicuous. In addition, exposure of lymphocytes to LTX-containing mutant LF induced no cell damage; the cells remained well preserved and ultrastructurally resembled lymphocytes activated in the absence of LTX.
Effect of LTX on Lymphocyte Functions
Evaluation of the ability of T cells to undergo activation was in agreement with ultrastructural findings. The surface expression of CD69 on T cells was 6.5-fold lower following treatment with LTX (Po0.0001) indicating severe impairment in lymphocyte activation (Figure 2a) . Moreover, the LTX-impaired activation of T lymphocytes was apparently associated with abnormalities in intracellular signaling (Figure 2b and c) . LTX initially reduced phosphorylation of p38 and by 30 min of exposure completely inhibited activation of this MAPK cascade (Figure 2b and c) . Signaling through p38 cascade remained inhibited over all the time that the cells had been exposed to LTX (data not shown). No effect of LTX was found on overall expression of p38 protein (Figure 2b ). The LTX-induced inactivation of T cells was clearly dependent on LF concentrations (Figure 3a) and time of exposure (Figure 3b) . Specificity of the LTX-induced effect was demonstrated by using a mutant LF, which was unable to cleave its cellular targets, 4, 5 and thus avoided decrease in CD69 expression (Figure 3a ) and p38 phosphorylation Figure 1 Ultrastructural appearance of activated human lymphocytes exposed to anthrax lethal toxin. A cell activated for 24 h by CD3 crosslinking (a) has an indented nucleus with marginated heterochromatin, wellpreserved microvilli and numerous mitochondria of variable size and shape. Electron-dense bodies, apparently small lysosomes, are frequent (arrows). In the center of the cell, transverse sections through Golgi cisterns and a few small electron-lucent vacuoles are visible. Treatment with LTX (b) reverses lymphocytes to the basic ultrastructure shown before activation: this cell appears similar to an untreated one, without signs of cell damage. A single electron-dense lysosome (arrow) is seen. An untreated cell (c) demonstrates the large nucleus, a few microvilli, and rare organelles in the cytoplasm: mitochondria, electron-dense lysosomes (arrows) and a few profiles of rough endoplasmic reticulum. TEM (uranyl acetate and lead citrate), original magnification, Â 10 000. (Figure 2b and c) . No effect was found when PA or LF was separately added to the cells (data not shown).
Effect of LTX on Lymphocyte Viability
In order to study the effect of LTX on T-lymphocyte survival, we determined percentages of apoptotic (annexin V-positive) and necrotic (PI positive) CD3 þ PBL. Despite the pronounced suppression of intracellular signaling, LTX did not increase the rate of T-cell apoptosis, which varied between 2.1 and 3.9% at different time points and LF concentrations (Figure 4) . Only prolonged exposure to a very high LF concentration (10 mg/ml) increased apoptosis rates, but the increase was not statistically significant (P ¼ 0.177), and was 2.9-folds lower than that induced by camptothecin (18.671.6%; P ¼ 0.01), a known apoptosis inducer 22 employed as positive control (Figure 4 ). In addition, percentages of membrane-compromised (necrotic) cells were steady low at different concentrations of LTX and at different time points after exposure (data not shown). 
In parallel, untreated cells, autofluorescence and relative isotypic controls were analyzed. Cells exposed to 2 mg/ml camptothecin (Sigma) served as positive control (squares). Data represent results from four experiments. ANOVA followed by NeumanKeuls test: *Po0.01 vs untreated cells (LF 0).
Effect of CQ on Ultrastructure and Functions of Lymphocytes Treated with LTX
Previous studies have shown that CQ protects isolated Mf or T lymphocytes from LTX. 14, 16, 17 Although when applied alone CQ had no substantial effect on T-cell activation, it restored the impaired expression of CD69 in T lymphocytes exposed to LTX (Figure 5a) , and significantly improved phosphorylation of p38 (Figure 5b and c) . We next investigated alterations of lymphocyte ultrastructure induced by CQ, and associated with its favorable effect on the LTXinduced dysfunction. Exposure of lymphocytes to CQ alone resulted in marked changes in cell ultrastructure (Figure 6a) . Frequent single-membrane-limited bodies with heterogeneous content were detected within the cytoplasm. These bodies, apparently phagolysosomes or autophagolysosomes contained abundant segregated compounds and/or cell debris. Additionally, a number of electron lucent vesicles and fat droplets were seen. Cells concomitantly treated with LTX and CQ showed similar ultrastructural changes. Nuclei were mildly indented, microvilli and mitochondria appeared preserved. In the cytoplasm, many lysosomes with various amorphous or membranous contents were observed (Figure  6b and c) .
DISCUSSION
In the present study, LTX impaired T-lymphocyte functions in a dose-and time-dependent manner, but not their viability, and did not induce structural damage. The main finding was ultrastructural evidence that CQ protected T-cells from LTX, possibly by interfering with lysosome activity.
Unlike Mf, which could be easily killed by anthrax toxins. 8, 9, 23 LTX did not affect the viability of T lymphocytes in either the present study or a previous report. 13 This phenomenon can be explained by the involvement of numerous independent systems, such as MAPK, PI3-Akt, JAK/STAT, PKCy and others in T-cell survival control. 24, 25 Thus, it is reasonable that parallel mechanisms hold the cell survival under control even when MAPK has been inactivated. However, the effects of LTX on signaling through other than MAPK regulatory pathways are still unknown and further efforts are requested to clarify this issue.
In concordance with determination of viability by flow cytometry, no signs indicating cellular damage were found using TEM. When CD3-crosslinked lymphocytes were treated with LTX, the ultrastructural features of untreated normal lymphocytes reappeared. Ferrarini et al 26 have described a subset of T lymphocytes in peripheral human blood, which display ultrastructural features identical to those of activated lymphocytes as seen in our study (Figure 1a) . Details of the method of cell purification and functional properties of isolated cells, primarily the expression of high-affinity receptors to IgG (CD64 by the current classification), strongly suggest that the authors observed activated lymphocytes. In summary, CD3 crosslinking produced ultrastructural features of lymphocyte activation, which were abrogated in the presence of LTX.
In contrast to the preserved ultrastructure and viability, LTX inhibited activation of T lymphocytes manifested by expression of CD69 in a dose-and time-dependent manner. This is consistent with our previous report and data of other investigators who have determined expression of CD69 and cytokines in LTX-treated lymphocytes. [12] [13] [14] [15] The novel information gathered during this study is characterization of cell ultrastructure changes associated with severe T-lymphocyte suppression in anthrax, as well as comparison of ultrastructural findings with functional tests (viability, activation, intracellular signaling).
The impaired T-lymphocyte activation was expectedly associated with MAPK inhibition. Both p38 (Figure 2) [12] [13] [14] [15] Specific character of these abnormalities was demonstrated using the mutant form of LF (Figure 2b and c) , which was unable to cleave its intracellular targets owing to a point mutation. 4, 5 CQ is an antimalarial agent, also used for treatment of chronic inflammatory and autoimmune diseases. 27 Mechanisms of antiinflammatory effects of CQ are not completely clear; most probably CQ interferes with presentation and recognition of antigens by blocking of lysosomal processing of major histocompatibility complex molecules. 27 An ability of CQ to inhibit proton pumps, and therefore disrupt proton gradients leading to lysosome pH decrease, has been amply documented. 27, 28 Acidification of lysosomes is a key event in the pathogenesis of anthrax, being essential for dissociation of internalized PA-LF complexes. Hence, agents interfering with this process may have practical applications. In fact, no dramatic effect of CQ per se on T-cell functions was observed. However, an apparently inhibiting effect on lysosome functioning was documented using TEM. Taken together, the finding of frequent lysosomes with heterogeneous content, in parallel with other well-preserved subcellular elements and organelles, suggests a selective damage to the processing of internalized and lysosome-compartmentalized material. These findings correspond well with the antilysosomal activity of CQ demonstrated biochemically, 16, 19, 29 and are consistent with data on the effect of inhibitors of lysosomal acidification on ultrastructure and functions of T-cell lysosomes. 30 CQ has protected Mf, 16, 17 epithelial cells 19 or T lymphocytes 14 from LTX, and even increased survival of LTX-treated mice. 18 In LTX-exposed lymphocytes, CQ improved phosphorylation of p38, and recovered transduction of the intracellular signals resulting in enhanced CD69 expression ( Figure 5 ). Most probably, these favorable effects of CQ were related to its inhibitory lysosomotropic activity ( Figure 6 ). It seems quite reasonable to propose that the impaired lysosome acidification prevents dissociation of internalized LF-PA complexes, and thereby avoids or greatly reduces the exposure of MAPKKs to enzymatically active LF. This suggestion is supported by the ultrastructural evidence of retention of abundant material in the lysosome compartment of lymphocytes. Our ultrastructural findings are similar to the previously described CQ-induced lysosome disorder, featured as appearance of large, foamy or granular autophagolysosomes; or collection of membranous vesicles in the lysosome (multivesicular body), subsequent to the progressive accumulation of cell membrane aggregates and myeloid bodies owing failure of enzymatic digestion. 31 In conclusion, our findings are the first to demonstrate that, despite the profound impairment of T-lymphocyte functions, LTX does not induce ultrastructural damage and does not affect cell viability. The favorable effect of CQ reducing the LTX-induced T-cell suppression is associated with ultrastructural evidence of abnormal lysosomal functioning.
